Table 1.

Patient characteristics ( n  = 6)

Patient no.	#02	#03	#04	#05	#06	#07
Age (years)	63	39	28	57	33	69
Sex	M	M	M	M	M	F
Disease state	Refractory	First relapse	Newly diagnosed	Newly diagnosed	Newly diagnosed	First relapse
Stage at diagnosis	IVB	IEA	IVB	IVB	IVB	IEA
Sites of involvement at diagnosis	Bone marrow, spleen	Nasal cavity	Waldeyer ring, lymph nodes, nasal cavity, bone marrow	Bilateral adrenal glands, pancreas, gallbladder	Nasopharynx, lymph nodes, small bowel	Nasal cavity
Initial treatment	CHOP × 2	CHOP × 2→RT →IMVP‐16	–	–	–	RT (42 Gy) →DeVIC × 4
Sites of involvement at registration	Bone marrow, spleen	Nasal cavity	Waldeyer ring, lymph nodes, nasal cavity, Bone marrow	Bilateral adrenal glands, pancreas, gallbladder	Nasopharynx, lymph nodes, small bowel	Nasal cavity, paranasal sinuses, cheek
PS	1	1	1	2	0	0
sLDH level	Elevated	Below the upper normal range	Elevated	Elevated	Below the upper normal range	Elevated

CHOP, cyclophosphamide, doxorubicin, vincristine, prednisolone; DeVIC, dexamethasone, etoposide, ifosfamide, carboplatin; IMVP‐16, ifosfamide, methotrexate, etoposide; PS, performance status; RT, radiotherapy; sLDH, serum lactate dehydrogenase.